At the WHO Global Forum for Public Procurement of Health Products, a powerful reminder was shared by WHO’s Director-General, Dr. Tedros Adhanom Ghebreyesus.
Today marks the launch of Global Biosimilars Week 2025, an international awareness campaign led by the International Generic and Biosimilar Medicines Association (IGBA). This year’s theme, “Biosimilars: A Wise Investment for Global Health,” highlights the growing importance of biosimilar medicines in improving access to treatment, enhancing healthcare sustainability, and promoting global health equity.
IGBA at UNGA Side Events.
- IGBA Welcomes the WHO Pandemic Agreement and Calls for Action on Key Elements (July 2025)
- IGBA Statement at the 66th Series of Meetings of the WIPO Assemblies (July 2025)
- Calling for health and access to health for all as a priority in the upcoming G7 Leaders’ Summit – An IGBA perspective (June 2025)
- IGBA Welcomes ICH New Topic for Harmonisation: Framework for Determining Utility of Comparative Efficacy Studies in Biosimilar Development Programs (May 2025)
